X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
double-blind method (6) 6
female (6) 6
male (6) 6
middle aged (6) 6
ticlopidine - analogs & derivatives (6) 6
clopidogrel (5) 5
drug therapy, combination (5) 5
aged (4) 4
aspirin (4) 4
cardiac & cardiovascular systems (4) 4
follow-up studies (4) 4
hemorrhage - chemically induced (4) 4
prospective studies (4) 4
risk factors (4) 4
ticlopidine - adverse effects (4) 4
cardiovascular disease (3) 3
cardiovascular diseases - drug therapy (3) 3
cardiovascular diseases - mortality (3) 3
dosage and administration (3) 3
drug therapy (3) 3
platelet aggregation inhibitors - administration & dosage (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
ticlopidine - administration & dosage (3) 3
ticlopidine - therapeutic use (3) 3
abridged index medicus (2) 2
acute coronary syndromes (2) 2
aspirin - administration & dosage (2) 2
aspirin - adverse effects (2) 2
aspirin - therapeutic use (2) 2
atheroembolism (2) 2
cardiology and cardiovascular medicine (2) 2
cardiovascular (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - prevention & control (2) 2
confidence intervals (2) 2
coronary vessels (2) 2
health aspects (2) 2
heart attack (2) 2
heart attacks (2) 2
index medicus (2) 2
internal medicine (2) 2
medicine, general & internal (2) 2
mortality (2) 2
myocardial-infarction (2) 2
peripheral vascular disease (2) 2
platelet aggregation inhibitors - therapeutic use (2) 2
prevention (2) 2
primary prevention (2) 2
risk (2) 2
stroke (2) 2
stroke - prevention & control (2) 2
therapy (2) 2
11-oxothromboxane b2 (1) 1
acute myocardial-infarction (1) 1
adult (1) 1
aged, 80 and over (1) 1
analysis (1) 1
article (1) 1
aspirin - pharmacology (1) 1
aspirin - urine (1) 1
aspirin resistance (1) 1
atherosclerosis (1) 1
atorvastatin (1) 1
body mass index (1) 1
cardiac patients (1) 1
cardiovascular diseases - etiology (1) 1
cardiovascular diseases - metabolism (1) 1
cardiovascular diseases - urine (1) 1
care and treatment (1) 1
cerebral hemorrhage - mortality (1) 1
cessation (1) 1
charisma trial (1) 1
cigarette-smoking (1) 1
clinical trials (1) 1
comparative analysis (1) 1
complications and side effects (1) 1
coronary (1) 1
cyclooxygenase inhibitors - pharmacology (1) 1
cytochrome p-450 (1) 1
cytochrome p-450 cyp3a (1) 1
cytochrome p-450 enzyme system - metabolism (1) 1
data interpretation, statistical (1) 1
development and progression (1) 1
disease (1) 1
drug dosages (1) 1
drug interactions (1) 1
events (1) 1
heart surgery (1) 1
hematology (1) 1
hemorrhage - etiology (1) 1
heptanoic acids - administration & dosage (1) 1
heptanoic acids - adverse effects (1) 1
heptanoic acids - metabolism (1) 1
hospitalization (1) 1
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (1) 1
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1) 1
hydroxymethylglutaryl-coa reductase inhibitors - metabolism (1) 1
influence (1) 1
internationality (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 49, Issue 19, pp. 1982 - 1988
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2006, Volume 354, Issue 16, pp. 1706 - 1717
Journal Article
Circulation, ISSN 0009-7322, 10/2008, Volume 118, Issue 17, pp. 1705 - 1712
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2007, Volume 50, Issue 4, pp. 291 - 295
Lack of Evidence of a Clopidogrel-Statin Interaction in the CHARISMA Trial Jacqueline Saw, Danielle M. Brennan, Steven R. Steinhubl, Deepak L. Bhatt, Koon-Hou... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | PLATELET INHIBITION | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Heptanoic Acids - metabolism | Prospective Studies | Follow-Up Studies | Cytochrome P-450 CYP3A | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Cytochrome P-450 Enzyme System - metabolism | Male | Heptanoic Acids - adverse effects | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Pyrroles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Heptanoic Acids - administration & dosage | Pravastatin - adverse effects | Pyrroles - adverse effects | Ticlopidine - administration & dosage | Female | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Pyrroles - metabolism | Cardiovascular Diseases - metabolism | Double-Blind Method | Pravastatin - metabolism | Ticlopidine - analogs & derivatives | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Pravastatin - administration & dosage | Atorvastatin | Clopidogrel | Hemorrhage - chemically induced | Analysis | Cytochrome P-450 | Studies | Confidence intervals | Body mass index | Stroke | Heart attacks | Heart surgery | Coronary vessels | Drug therapy | Acute coronary syndromes | Drug dosages | Statins | Veins & arteries
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2006, Volume 355, Issue 4, pp. 418 - 421
To the Editor: In the April 20 issue Bhatt et al. reported the results of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization,... 
MEDICINE, GENERAL & INTERNAL | Stroke - prevention & control | Ticlopidine - therapeutic use | Humans | Cerebral Hemorrhage - mortality | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Ticlopidine - analogs & derivatives
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.